Author

Albert Lai

Primary ORCID profile (0000-0002-7265-2986 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Albert LaiiD1 paper · University of California, Los Angeles

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alvaro G. AlvaradoiD· 1 shared Brandon Gruender· 1 shared Haocheng Qi· 1 shared Harley I. KornblumiD· 1 shared Lubayna S. Elahi· 1 shared Maria G. Castro· 1 shared Matthew C. Garrett· 1 shared Michael C. CondroiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alvaro G. AlvaradoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivNov 15, 2023

De novo lipogenesis pathway is a vulnerability in IDH1 mutant glioma

Lubayna S. Elahi, Michael C. Condro, Riki Kawaguchi…·Harley I. Kornblum

This study identifies de novo lipogenesis as a vulnerability in IDH1 mutant gliomas, showing that HDAC inhibition and FASN targeting reduce tumor growth and improve survival.

DOI 10.1038/s44324-024-00021-6

humanbulk RNA-seq

𝕏 PostBluesky